Data / Form D filings / Ausel, Inc.
Ausel, Inc.: Form D filing
Ausel, Inc., a biotechnology company in Carlsbad, CA, filed a Form D with the SEC in 2026. The latest, on November 4, 2026, reports $120,000 sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2871 RANCHO CORTES, Carlsbad, CA, 92009
- Phone
- (858) 337-6454
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2124022
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | New notice | $5,000,000 | $120,000 | $4,880,000 | 1 | Oct 22, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nicholas Ainslie | Executive Officer, Director | Chief Executive Officer and Chief Financial Officer |
| Paul Evan Shockley | Executive Officer, Director | Chief Operating Officer and Secretary |
| Prisco Piscitelli | Executive Officer | Chief Medical Officer |
| Paul Ainslie | Director | Chairman of the Board of Directors |
| Robert Ainslie | Promoter | Non-operating founder |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Nov 2, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ausel, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.